Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsTransCode Therapeutics, Inc. announced that it has received Orphan Drug Designation from the US FDA for its lead therapeutic candidate, TTX-MC138, in pancreatic cancer.
[TransCode Therapeutics, Inc.]
Home Newsletters TransCode Therapeutics Announces Orphan Drug Designation Status for TTX-Mc138 for Treatment of...
